{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T09:47:15Z","timestamp":1695116835146},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T00:00:00Z","timestamp":1564444800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T00:00:00Z","timestamp":1564444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00108-019-0644-1","type":"journal-article","created":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T08:04:11Z","timestamp":1564473851000},"page":"987-995","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Heredit\u00e4res Angio\u00f6dem","Hereditary angioedema"],"prefix":"10.1007","volume":"60","author":[{"given":"Emel","family":"Ayg\u00f6ren-P\u00fcrs\u00fcn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konrad","family":"Bork","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,30]]},"reference":[{"issue":"9225","key":"644_CR1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0140-6736(00)02483-1","volume":"356","author":"K Bork","year":"2000","unstructured":"Bork\u00a0K, Barnstedt\u00a0SE, Koch\u00a0P, Traupe\u00a0H (2000) Hereditary angioedema with normal C1-inhibitor activity in women. Lancet 356(9225):213\u2013217","journal-title":"Lancet"},{"issue":"2","key":"644_CR2","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s12016-016-8543-x","volume":"51","author":"AE Germenis","year":"2016","unstructured":"Germenis\u00a0AE, Speletas\u00a0M (2016) Genetics of hereditary Angioedema revisited. Clin Rev Allergy Immunol 51(2):170\u2013182","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"644_CR3","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.bbrc.2006.03.092","volume":"343","author":"G Dewald","year":"2006","unstructured":"Dewald\u00a0G, Bork\u00a0K (2006) Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. Biochem Biophys Res Commun 343(4):1286\u20131289","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"644_CR4","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1111\/jth.14209","volume":"16","author":"S De Maat","year":"2018","unstructured":"De Maat\u00a0S, Hofman\u00a0ZLM, Maas\u00a0C (2018) Hereditary angioedema: the plasma contact system out of control. J\u00a0Thromb Haemost 16(9):1674\u20131685","journal-title":"J Thromb Haemost"},{"issue":"2","key":"644_CR5","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/all.13270","volume":"73","author":"K Bork","year":"2018","unstructured":"Bork\u00a0K, Wulff\u00a0K, Steinmuller-Magin\u00a0L, Braenne\u00a0I, Staubach-Renz\u00a0P, Witzke\u00a0G et al (2018) Hereditary angioedema with a\u00a0mutation in the plasminogen gene. Allergy 73(2):442\u2013450","journal-title":"Allergy"},{"issue":"3","key":"644_CR6","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.jaci.2017.05.020","volume":"141","author":"V Bafunno","year":"2018","unstructured":"Bafunno\u00a0V, Firinu\u00a0D, D\u2019Apolito\u00a0M, Cordisco\u00a0G, Loffredo\u00a0S, Leccese\u00a0A et al (2018) Mutation of the angiopoietin-1 gene (ANGPT1) associates with a\u00a0new type of hereditary angioedema. J\u00a0Allergy Clin Immunol 141(3):1009\u20131017","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"644_CR7","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1111\/all.12714","volume":"70","author":"M Speletas","year":"2015","unstructured":"Speletas\u00a0M, Szilagyi\u00a0A, Csuka\u00a0D, Koutsostathis\u00a0N, Psarros\u00a0F, Moldovan\u00a0D et al (2015) F12-46C\/T polymorphism as modifier of the clinical phenotype of hereditary angioedema. Allergy 70(12):1661\u20131664","journal-title":"Allergy"},{"issue":"3\u20134","key":"644_CR8","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1159\/000481987","volume":"174","author":"P Gianni","year":"2017","unstructured":"Gianni\u00a0P, Loules\u00a0G, Zamanakou\u00a0M, Kompoti\u00a0M, Csuka\u00a0D, Psarros\u00a0F et\u00a0al (2017) Genetic determinants of C1 inhibitor deficiency angioedema age of onset. Int Arch Allergy Immunol 174(3\u20134):200\u2013204","journal-title":"Int Arch Allergy Immunol"},{"issue":"1","key":"644_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13023-018-0815-5","volume":"13","author":"E Ayg\u00f6ren-P\u00fcrs\u00fcn","year":"2018","unstructured":"Ayg\u00f6ren-P\u00fcrs\u00fcn\u00a0E, Magerl\u00a0M, Maetzel\u00a0A, Maurer\u00a0M (2018) Epidemiology of Bradykinin-mediated angioedema: a\u00a0systematic investigation of epidemiological studies. Orphanet J Rare Dis 13(1):73","journal-title":"Orphanet J Rare Dis"},{"key":"644_CR10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3389\/fmed.2017.00121","volume":"4","author":"F Simao","year":"2017","unstructured":"Simao\u00a0F, Feener\u00a0EP (2017) The effects of the contact activation system on hemorrhage. Front Med (lausanne) 4:121","journal-title":"Front Med (lausanne)"},{"issue":"5","key":"644_CR11","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1016\/j.jaci.2016.02.021","volume":"138","author":"S de Maat","year":"2016","unstructured":"de Maat\u00a0S, Bjorkqvist\u00a0J, Suffritti\u00a0C, Wiesenekker\u00a0CP, Nagtegaal\u00a0W, Koekman\u00a0A et\u00a0al (2016) Plasmin is a\u00a0natural trigger for bradykinin production in patients with hereditary angioedema with factor XII mutations. J\u00a0Allergy Clin Immunol 138(5):1414\u20131423","journal-title":"J Allergy Clin Immunol"},{"key":"644_CR12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13601-018-0229-4","volume":"8","author":"A Zanichelli","year":"2018","unstructured":"Zanichelli\u00a0A, Magerl\u00a0M, Longhurst\u00a0HJ, Aberer\u00a0W, Caballero\u00a0T, Bouillet\u00a0L et\u00a0al (2018) Improvement in diagnostic delays over time in patients with hereditary angioedema: findings from the Icatibant Outcome Survey. Clin Transl Allergy 8:42","journal-title":"Clin Transl Allergy"},{"issue":"1","key":"644_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2500\/aap.2013.34.3685","volume":"35","author":"T Caballero","year":"2014","unstructured":"Caballero\u00a0T, Ayg\u00f6ren-P\u00fcrs\u00fcn\u00a0E, Bygum\u00a0A, Beusterien\u00a0K, Hautamaki\u00a0E, Sisic\u00a0Z et al (2014) The humanistic burden of hereditary angioedema: results from the Burden of Illness Study in Europe. Allergy Asthma Proc 35(1):47\u201353","journal-title":"Allergy Asthma Proc"},{"issue":"3","key":"644_CR14","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/j.1572-0241.2006.00492.x","volume":"101","author":"K Bork","year":"2006","unstructured":"Bork\u00a0K, Staubach\u00a0P, Eckardt\u00a0AJ, Hardt\u00a0J (2006) Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency. Am J Gastroenterol 101(3):619\u2013627","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"644_CR15","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jaci.2012.05.055","volume":"130","author":"K Bork","year":"2012","unstructured":"Bork\u00a0K, Hardt\u00a0J, Witzke\u00a0G (2012) Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency. J\u00a0Allergy Clin Immunol 130(3):692\u2013697","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"644_CR16","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1111\/all.12186","volume":"68","author":"E Ayg\u00f6ren-P\u00fcrs\u00fcn","year":"2013","unstructured":"Ayg\u00f6ren-P\u00fcrs\u00fcn\u00a0E, Martinez Saguer\u00a0I, Kreuz\u00a0W, Klingebiel\u00a0T, Schwabe\u00a0D (2013) Risk of angioedema following invasive or surgical procedures in HAE type I and II\u2014the natural history. Allergy 68(8):1034\u20131039","journal-title":"Allergy"},{"issue":"1","key":"644_CR17","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.tripleo.2011.02.034","volume":"112","author":"K Bork","year":"2011","unstructured":"Bork\u00a0K, Hardt\u00a0J, Staubach-Renz\u00a0P, Witzke\u00a0G (2011) Risk of laryngeal edema and facial swellings after tooth extraction in patients with hereditary angioedema with and without prophylaxis with C1 inhibitor concentrate: a\u00a0retrospective study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112(1):58\u201364","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"644_CR18","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.2147\/PPA.S100383","volume":"10","author":"E Ayg\u00f6ren-P\u00fcrs\u00fcn","year":"2016","unstructured":"Ayg\u00f6ren-P\u00fcrs\u00fcn\u00a0E, Bygum\u00a0A, Beusterien\u00a0K, Hautamaki\u00a0E, Sisic\u00a0Z, Boysen\u00a0HB et al (2016) Estimation of EuroQol 5\u2011Dimensions health status utility values in hereditary angioedema. Patient Prefer Adherence 10:1699\u20131707","journal-title":"Patient Prefer Adherence"},{"key":"644_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1750-1172-9-99","volume":"9","author":"E Ayg\u00f6ren-P\u00fcrs\u00fcn","year":"2014","unstructured":"Ayg\u00f6ren-P\u00fcrs\u00fcn\u00a0E, Bygum\u00a0A, Beusterien\u00a0K, Hautamaki\u00a0E, Sisic\u00a0Z, Wait\u00a0S et al (2014) Socioeconomic burden of hereditary angioedema: results from the hereditary angioedema burden of illness study in Europe. Orphanet J Rare Dis 9:99","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"644_CR20","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/all.13076","volume":"72","author":"K Bork","year":"2017","unstructured":"Bork\u00a0K, Wulff\u00a0K, Witzke\u00a0G, Hardt\u00a0J (2017) Treatment for hereditary angioedema with normal C1-INH and specific mutations in the F12 gene (HAE-FXII). Allergy 72(2):320\u2013324","journal-title":"Allergy"},{"issue":"1","key":"644_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.5414\/ALX02059","volume":"42","author":"E Ayg\u00f6ren-P\u00fcrs\u00fcn","year":"2019","unstructured":"Ayg\u00f6ren-P\u00fcrs\u00fcn\u00a0E (2019) Heredit\u00e4re Angio\u00f6deme \u2013 Aktuelle und zuk\u00fcnftige Therapien. Allergologie 42(1):31\u201338","journal-title":"Allergologie"},{"issue":"2","key":"644_CR22","doi-asserted-by":"publisher","first-page":"e53773","DOI":"10.1371\/journal.pone.0053773","volume":"8","author":"M Maurer","year":"2013","unstructured":"Maurer\u00a0M, Aberer\u00a0W, Bouillet\u00a0L, Caballero\u00a0T, Fabien\u00a0V, Kanny\u00a0G et\u00a0al (2013) Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment. PLoS ONE 8(2):e53773","journal-title":"PLoS ONE"},{"issue":"8","key":"644_CR23","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1111\/all.13384","volume":"73","author":"M Maurer","year":"2018","unstructured":"Maurer\u00a0M, Magerl\u00a0M, Ansotegui\u00a0I, Ayg\u00f6ren-P\u00fcrs\u00fcn\u00a0E, Betschel\u00a0S, Bork\u00a0K et al (2018) The international WAO\/EAACI guideline for the management of hereditary angioedema\u2014The 2017 revision and update. Allergy 73(8):1575\u20131596","journal-title":"Allergy"},{"key":"644_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s40629-018-0088-5","volume":"28","author":"K Bork","year":"2019","unstructured":"Bork\u00a0K, Ayg\u00f6ren-P\u00fcrs\u00fcn\u00a0E, Bas\u00a0M, Biedermann\u00a0T, Greve\u00a0J, Hartmann\u00a0K et al (2019) Guideline: Hereditary angioedema due to C1 inhibitor deficiency. Allergo J Int 28:16\u201329","journal-title":"Allergo J Int"},{"issue":"12","key":"644_CR25","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1056\/NEJMoa1613627","volume":"376","author":"H Longhurst","year":"2017","unstructured":"Longhurst\u00a0H, Cicardi\u00a0M, Craig\u00a0T, Bork\u00a0K, Grattan\u00a0C, Baker\u00a0J et\u00a0al (2017) Prevention of hereditary Angioedema attacks with a\u00a0subcutaneous C1 inhibitor. N\u00a0Engl J Med 376(12):1131\u20131140","journal-title":"N Engl J Med"},{"issue":"20","key":"644_CR26","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1001\/jama.2018.16773","volume":"320","author":"A Banerji","year":"2018","unstructured":"Banerji\u00a0A, Riedl\u00a0MA, Bernstein\u00a0JA, Cicardi\u00a0M, Longhurst\u00a0HJ, Zuraw\u00a0BL et\u00a0al (2018) Effect of Lanadelumab compared with placebo on prevention of hereditary Angioedema attacks: a randomized clinical trial. JAMA 320(20):2108\u20132121","journal-title":"JAMA"},{"issue":"3","key":"644_CR27","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jaci.2016.03.043","volume":"138","author":"E Ayg\u00f6ren-P\u00fcrs\u00fcn","year":"2016","unstructured":"Ayg\u00f6ren-P\u00fcrs\u00fcn\u00a0E, Magerl\u00a0M, Graff\u00a0J, Martinez-Saguer\u00a0I, Kreuz\u00a0W, Longhurst\u00a0H et al (2016) Prophylaxis of hereditary angioedema attacks: a randomized trial of oral plasma kallikrein inhibition with avoralstat. J\u00a0Allergy Clin Immunol 138(3):934\u2013936","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"644_CR28","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1111\/all.13466","volume":"73","author":"MA Riedl","year":"2018","unstructured":"Riedl\u00a0MA, Ayg\u00f6ren-P\u00fcrs\u00fcn\u00a0E, Baker\u00a0J, Farkas\u00a0H, Anderson\u00a0J, Bernstein\u00a0JA et al (2018) Evaluation of avoralstat, an oral kallikrein inhibitor, in a\u00a0Phase 3 hereditary angioedema prophylaxis trial: The OPuS-2 study. Allergy 73(9):1871\u20131880","journal-title":"Allergy"},{"issue":"4","key":"644_CR29","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1056\/NEJMoa1716995","volume":"379","author":"E Ayg\u00f6ren-P\u00fcrs\u00fcn","year":"2018","unstructured":"Ayg\u00f6ren-P\u00fcrs\u00fcn\u00a0E, Bygum\u00a0A, Grivcheva-Panovska\u00a0V, Magerl\u00a0M, Graff\u00a0J, Steiner\u00a0UC et al (2018) Oral plasma Kallikrein inhibitor for prophylaxis in hereditary Angioedema. N\u00a0Engl J Med 379(4):352\u2013362","journal-title":"N Engl J Med"},{"issue":"17","key":"644_CR30","first-page":"247","volume":"3","author":"M Worm","year":"2015","unstructured":"Worm\u00a0M, Kohler\u00a0EC, Panda\u00a0R, Long\u00a0A, Butler\u00a0LM, Stavrou\u00a0EX et al (2015) The factor XIIa blocking antibody 3F7: a\u00a0safe anticoagulant with anti-inflammatory activities. Ann Transl Med 3(17):247","journal-title":"Ann Transl Med"},{"issue":"6","key":"644_CR31","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/all.13582","volume":"74","author":"T Qiu","year":"2018","unstructured":"Qiu\u00a0T, Chiuchiolo\u00a0MJ, Whaley\u00a0AS, Russo\u00a0AR, Sondhi\u00a0D, Kaminsky\u00a0SM et\u00a0al (2018) Gene therapy for C1 Esterase inhibitor deficiency in a\u00a0murine model of hereditary Angioedema. Allergy 74(6):1081\u20131089","journal-title":"Allergy"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-019-0644-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-019-0644-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-019-0644-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T17:29:13Z","timestamp":1695058153000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-019-0644-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,30]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["644"],"URL":"https:\/\/doi.org\/10.1007\/s00108-019-0644-1","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,30]]},"assertion":[{"value":"30 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"E.\u00a0Ayg\u00f6ren-P\u00fcrs\u00fcn erhielt Honorarzahlungen f\u00fcr Beratert\u00e4tigkeit, Advisory Board und\/oder Vortr\u00e4ge von den Firmen Adverum, BioCryst, CSL Behring, KalVista, Pharming, Shire\/Takeda. Sie f\u00fchrte klinische Studien f\u00fcr die Firmen BioCryst, CSL Behring und Shire durch und\/oder erhielt von ihnen Forschungsf\u00f6rderung. K.\u00a0Bork erhielt Vortragshonorare von CSL Behring und Shire.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}